IL17A and psoriasis: In vivo, the microneedles successfully penetrated both normal and psoriatic mouse skin (~150 μm), dissolved within 10 min, and significantly reduced epidermal thickness, ear swelling, and cytokine expression (IL-17, IL-23, Ki67) in an imiquimod-induced psoriasis model.